-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Semnur Pharmaceuticals, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2022 to 31 Dec 2025.
- Semnur Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $114,131, a 69% increase year-over-year.
- Semnur Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $5,867,000, a 20% decline from 2024.
- Semnur Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $4,891,000, a 673% decline from 2023.
- Semnur Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $632,783, a 49% decline from 2022.